News & Updates

Surgeons at the Chinese University of Hong Kong (CUHK) and the Swiss Federal Institute of Technology Zurich (ETH Zurich) have become the first in the world to perform teleoperated magnetic endoscopy in a porcine model across a distance of 9,300 km.

A safety signal for acute pancreatitis among users of the calcineurin inhibitor (CNI) tacrolimus has been identified in an observational retrospective pharmacovigilance study.

Treatment with liposomal irinotecan plus 5-fluorouracil, leucovorin, and oxaliplatin (NALIRIFOX) improved overall survival (OS) and progression-free survival (PFS) in patients aged ≥65 years with metastatic pancreatic ductal adenocarcinoma (mPDAC) compared with gemcitabine plus nab-paclitaxel (Gem+NabP), according to a post hoc analysis of the phase III NAPOLI 3 trial presented at ESMO GI 2024.

New drug applications approved by US FDA as of 1-15 August 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of a powder agent, either as monotherapy or in combination with other conventional therapy, appears to be safe and effective for endoscopic haemostasis in children with acute upper gastrointestinal (GI) bleeding (UGIB), according to real-world data from Singapore.